Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|3|374-379

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.3, 2015-05, pp. : 374-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 320-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haemophilia pseudotumours in patients with inhibitors

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : 681-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haemophilia pseudotumours in patients with inhibitors

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : 681-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence for the Use of Activated Prothrombin Complex Concentrates (aPCCs) in the Treatment of Patients with Haemophilia and Inhibitors

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 9-12

Karger

Access to resources Recommend Favorite

How I manage patients with inherited haemophilia A and B and factor inhibitors

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 501-510

John Wiley & Sons Inc

Access to resources Recommend Favorite